ClinicalTrials.Veeva

Menu

Evaluation of the MORENO Score for the Regulation (ESMORTSAB19)

R

Regional University Hospital Center (CHRU)

Status

Completed

Conditions

the Safety / Feasibility /MORENO Score/Regulation / Secondary Transfers / SAMU 29 / Current Practices

Study type

Observational

Funder types

Other

Identifiers

NCT06555874
29BRC20.0075

Details and patient eligibility

About

The main objective of this work is therefore to evaluate the safety and feasibility of the MORENO score for the regulation of secondary transfers to the SAMU 29 compared to current practices.

Full description

Today, there is an increase in the number of secondary transfers and paramedical transport between the different hospitals in a territory. They have been promoted by the SFMU (French Society of Emergency Medicine) since 2012.

The sharp increase in the number of calls for SAMU regulation means that decisions must be made quickly and safely regarding transport requiring or not requiring a medical presence. The development of a decision support tool for the level of medicalisation of a transfer therefore seems necessary. However, there is currently no recommendation in France.

The MORENO score has already been used in a hospital in the Var, as well as in Spain and Greece. Prior validation of this score in our health territory is essential before setting up an operational procedure. Using a list of simple clinical items, this score enables us to assess whether or not it is necessary to medicalise a transfer.

Enrollment

1,500 patients

Sex

All

Ages

18 to 120 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All adult patients having benefited from a transfer regulated by the SAMU 29 of adult patients on the Finistère territory over a predefined period of time

Exclusion criteria

  • Pediatric patient transfers
  • Maritime transfers
  • Transfers for which the collected information does not allow to establish the MORENO score.
  • Patients under judicial protection (guardianship, curatorship,..)
  • Opposition

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems